ENDOSTATIN: 82 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
82
Total FAERS Reports
8 (9.8%)
Deaths Reported
24
Hospitalizations
82
As Primary/Secondary Suspect
7
Life-Threatening
First Report: 201102 · Latest Report: 20250802
What Are the Most Common ENDOSTATIN Side Effects?
#1 Most Reported
Myelosuppression
21 reports (25.6%)
#2 Most Reported
Nausea
10 reports (12.2%)
#3 Most Reported
White blood cell count decreased
7 reports (8.5%)
All ENDOSTATIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 21 | 25.6% | 0 | 9 |
| Nausea | 10 | 12.2% | 3 | 1 |
| Bone marrow failure | 7 | 8.5% | 1 | 0 |
| Gastrointestinal disorder | 7 | 8.5% | 0 | 0 |
| Hepatic function abnormal | 7 | 8.5% | 1 | 1 |
| White blood cell count decreased | 7 | 8.5% | 0 | 3 |
| Disease progression | 6 | 7.3% | 3 | 0 |
| Hypertension | 6 | 7.3% | 2 | 0 |
| Leukopenia | 6 | 7.3% | 2 | 0 |
| Vomiting | 6 | 7.3% | 1 | 0 |
| Gastrointestinal toxicity | 5 | 6.1% | 0 | 0 |
Who Reports ENDOSTATIN Side Effects? Age & Gender Data
Gender: 47.5% female, 52.5% male. Average age: 56.3 years. Most reports from: CN. View detailed demographics →
Is ENDOSTATIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2011 | 1 | 1 | 0 |
| 2016 | 2 | 0 | 0 |
| 2017 | 1 | 0 | 0 |
| 2018 | 1 | 0 | 0 |
| 2019 | 1 | 0 | 0 |
| 2020 | 2 | 0 | 0 |
| 2021 | 7 | 0 | 3 |
| 2022 | 5 | 0 | 3 |
| 2023 | 3 | 0 | 1 |
| 2024 | 13 | 0 | 8 |
| 2025 | 2 | 0 | 2 |
What Is ENDOSTATIN Used For?
| Indication | Reports |
|---|---|
| Lung neoplasm malignant | 15 |
| Chemotherapy | 5 |
Official FDA Label for ENDOSTATIN
Official prescribing information from the FDA-approved drug label.